MRVI

MKT CAP:$2B

Maravai Lifesciences Holdings Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$7.04+$3.64 (+107.06%)

Jul 15, 2026

52W High $7.0452W Low $2.02

Company Details

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa...

Leadership

Robert Andrew Eckert M.B.A.

Chairman of the Board

Bernd Brust

CEO & Director

Rajesh J. Asorpota

EVP & Chief Financial Officer

Kurt A. Oreshack J.D.

Executive VP, General Counsel & Secretary

Christine Dolan

Executive VP & GM of Cygnus Technologies

Chanfeng Zhao

Senior VP & Chief Scientific Officer

Debra Hart

Senior Director of Investor Relations

Judith A. Solecki

Senior VP & Chief Human Resources Officer

Kate E. Broderick Ph.D.

Executive Vice President

Christopher C. Benoit

Executive VP & Advisor

IPO Date

Nov 20, 2020

Website

www.maravai.com

Key Metrics TTM

Revenue

$205M

-15.4% YoY

Net Income

-$105M

EPS (Diluted)

Free Cash Flow

-$52M

Revenue / Share

$1.40

Gross Margin

29.0%

Operating Margin

21.9%

Net Margin

-51.1%

FCF Margin

-25.3%

P/S

8.6x

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Revenue by Geography

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee